Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends

Clin Drug Investig. 2022 Nov;42(11):1019-1020. doi: 10.1007/s40261-022-01212-z.

Arnaldo Figueiredo^{1

2}, Luís Costa^{3

4}, Maria Joaquina Maurício⁵, Luís Figueira^{6

7}, Rodrigo Ramos⁸, Carlos Martins-da-Silva⁹

¹ Department of Urology, University and Hospital Center of Coimbra, Praceta Prof. Mota Pinto, 3004-561, Coimbra, Portugal. ajcfigueiredo@chuc.min-saude.pt.
² Faculty of Medicine, University of Coimbra, Coimbra, Portugal. ajcfigueiredo@chuc.min-saude.pt.
³ Oncology Department, Santa Maria Hospital, North Lisbon University Hospital Centre, Lisboa, Portugal.
⁴ João Lobo Antunes Molecular Medicine Institute, Faculty of Medicine, University of Lisbon, Lisboa, Portugal.
⁵ Department of Medical Oncology, Portuguese Institute of Oncology, Porto, Portugal.
⁶ Department of Clinical Pharmacology, University Hospital Center of S. João, Porto, Portugal.
⁷ Center for Drug Discovery and Innovative Medicines (MedInUP) of the University of Porto, Porto, Portugal.
⁸ Department of Urology, Portuguese Institute of Oncology, Lisboa, Portugal.
⁹ Department of Urology, University Hospital Center of S. João, Faculty of Medicine of the University of Porto, Porto, Portugal.

No abstract available

Publication types